Acquisition-hungry Medtronic buys leading stent maker
This article was originally published in Clinica
Executive Summary
Medtronic will significantly boost its interventional cardiology business through the acquisition of leading stent manufacturer Arterial Vascular Engineering (AVE) in a $3.7 billion transaction. The deal is the latest in a string of acquisitions by Medtronic this year, which are expected to almost double the company's turnover to $5 billion in the next fiscal year.